Vaccine Maker's Toolkit: Strategies For Manufacturing And Supply Management

Vaccination is the most powerful and cost-effective way to protect billions of people around the world and has contributed immensely to global health. This collection of articles, produced through a partnership between MilliporeSigma and Bioprocess Online, highlights the need for ongoing investment in resilient biomanufacturing capacity and supply chains to ensure the reliable delivery of health technologies like vaccines, even during crisis conditions. We share strategies, drawn on MilliporeSigma's experience during the pandemic response, to achieve this outcome, focusing on vaccines manufactured by biotechnology companies and institutes.

Explore guidance from other industry experts on building scalable and need-specific supply chain operations, approaches to alleviate some of the challenges associated with using custom raw materials like mRNA, the benefits and impact of innovations in vaccine purification methods caused by the introduction of novel methods, the potential of mRNA-based and viral-vector-based vaccines, and more.